Metraipolis › archive › dc_7a7aafeff56c
Real-world efficacy and safety of anlotinib in Chinese solid tumors patients with liver metastases: a multicenter retrospective study — Europe PMC PMID:42222141
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42222141
- DOI
- 10.3389/fphar.2026.1639934
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T17:13:31.582Z
- SHA-256 of the archived text
28f421b5a0f08a5f1a0366cc99b71b15128995bc03d6c974aa11ce84f9ad23ad- Stable URL of this page
https://metraipolis.com/documento/dc_7a7aafeff56c
How to cite
Real-world efficacy and safety of anlotinib in Chinese solid tumors patients with liver metastases: a multicenter retrospective study — Europe PMC PMID:42222141 — Europe PMC (en), https://europepmc.org/article/MED/42222141 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7a7aafeff56c (Metraipolis archive dc_7a7aafeff56c, sha256 28f421b5a0f08a5f1a0366cc99b71b15128995bc03d6c974aa11ce84f9ad23ad)
BibTeX
@misc{dc7a7aafeff56c,
title = {Real-world efficacy and safety of anlotinib in Chinese solid tumors patients with liver metastases: a multicenter retrospective study — Europe PMC PMID:42222141},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42222141},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7a7aafeff56c; sha256 28f421b5a0f08a5f1a0366cc99b71b15128995bc03d6c974aa11ce84f9ad23ad},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42222141. Agents can read the archived copy with the MCP tool read_document.